01 2TEVA BRANDED PHARM
02 14TEVA PHARM
01 168978966
01 16Blank
01 16Y
01 162032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205636
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205636
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
Patent Expiration Date : 2032-01-13
US Patent Number : 8978966
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-01-13
